IBDEI2NI ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,44491,1,3,0)
 ;;=3^Malig Neop Right Adrenal Gland,Secondary
 ;;^UTILITY(U,$J,358.3,44491,1,4,0)
 ;;=4^C79.71
 ;;^UTILITY(U,$J,358.3,44491,2)
 ;;=^5001356
 ;;^UTILITY(U,$J,358.3,44492,0)
 ;;=C78.01^^200^2228^153
 ;;^UTILITY(U,$J,358.3,44492,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44492,1,3,0)
 ;;=3^Malig Neop Right Lung,Secondary
 ;;^UTILITY(U,$J,358.3,44492,1,4,0)
 ;;=4^C78.01
 ;;^UTILITY(U,$J,358.3,44492,2)
 ;;=^5001335
 ;;^UTILITY(U,$J,358.3,44493,0)
 ;;=C79.70^^200^2228^104
 ;;^UTILITY(U,$J,358.3,44493,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44493,1,3,0)
 ;;=3^Malig Neop Adrenal Gland Unspec,Secondary
 ;;^UTILITY(U,$J,358.3,44493,1,4,0)
 ;;=4^C79.70
 ;;^UTILITY(U,$J,358.3,44493,2)
 ;;=^5001355
 ;;^UTILITY(U,$J,358.3,44494,0)
 ;;=C78.00^^200^2228^137
 ;;^UTILITY(U,$J,358.3,44494,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44494,1,3,0)
 ;;=3^Malig Neop Lung Unspec,Secondary
 ;;^UTILITY(U,$J,358.3,44494,1,4,0)
 ;;=4^C78.00
 ;;^UTILITY(U,$J,358.3,44494,2)
 ;;=^5001334
 ;;^UTILITY(U,$J,358.3,44495,0)
 ;;=D57.1^^200^2228^178
 ;;^UTILITY(U,$J,358.3,44495,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44495,1,3,0)
 ;;=3^Sickle-Cell Disease w/o Crisis
 ;;^UTILITY(U,$J,358.3,44495,1,4,0)
 ;;=4^D57.1
 ;;^UTILITY(U,$J,358.3,44495,2)
 ;;=^5002309
 ;;^UTILITY(U,$J,358.3,44496,0)
 ;;=D75.1^^200^2228^176
 ;;^UTILITY(U,$J,358.3,44496,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44496,1,3,0)
 ;;=3^Polycythemia,Secondary
 ;;^UTILITY(U,$J,358.3,44496,1,4,0)
 ;;=4^D75.1
 ;;^UTILITY(U,$J,358.3,44496,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,44497,0)
 ;;=C90.30^^200^2228^179
 ;;^UTILITY(U,$J,358.3,44497,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44497,1,3,0)
 ;;=3^Solitary Plasmacytoma,Not in Remission
 ;;^UTILITY(U,$J,358.3,44497,1,4,0)
 ;;=4^C90.30
 ;;^UTILITY(U,$J,358.3,44497,2)
 ;;=^5001759
 ;;^UTILITY(U,$J,358.3,44498,0)
 ;;=D56.3^^200^2228^180
 ;;^UTILITY(U,$J,358.3,44498,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44498,1,3,0)
 ;;=3^Thalassemia Minor
 ;;^UTILITY(U,$J,358.3,44498,1,4,0)
 ;;=4^D56.3
 ;;^UTILITY(U,$J,358.3,44498,2)
 ;;=^340497
 ;;^UTILITY(U,$J,358.3,44499,0)
 ;;=D56.9^^200^2228^181
 ;;^UTILITY(U,$J,358.3,44499,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44499,1,3,0)
 ;;=3^Thalassemia,Unspec
 ;;^UTILITY(U,$J,358.3,44499,1,4,0)
 ;;=4^D56.9
 ;;^UTILITY(U,$J,358.3,44499,2)
 ;;=^340606
 ;;^UTILITY(U,$J,358.3,44500,0)
 ;;=M31.1^^200^2228^183
 ;;^UTILITY(U,$J,358.3,44500,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44500,1,3,0)
 ;;=3^Thrombotic Microangiopathy
 ;;^UTILITY(U,$J,358.3,44500,1,4,0)
 ;;=4^M31.1
 ;;^UTILITY(U,$J,358.3,44500,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,44501,0)
 ;;=D51.2^^200^2228^184
 ;;^UTILITY(U,$J,358.3,44501,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44501,1,3,0)
 ;;=3^Transcobalamin II Deficiency
 ;;^UTILITY(U,$J,358.3,44501,1,4,0)
 ;;=4^D51.2
 ;;^UTILITY(U,$J,358.3,44501,2)
 ;;=^5002286
 ;;^UTILITY(U,$J,358.3,44502,0)
 ;;=D05.92^^200^2228^33
 ;;^UTILITY(U,$J,358.3,44502,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44502,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,44502,1,4,0)
 ;;=4^D05.92
 ;;^UTILITY(U,$J,358.3,44502,2)
 ;;=^5001937
 ;;^UTILITY(U,$J,358.3,44503,0)
 ;;=D05.91^^200^2228^35
 ;;^UTILITY(U,$J,358.3,44503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44503,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,44503,1,4,0)
 ;;=4^D05.91
 ;;^UTILITY(U,$J,358.3,44503,2)
 ;;=^5001936
 ;;^UTILITY(U,$J,358.3,44504,0)
 ;;=D05.90^^200^2228^31
 ;;^UTILITY(U,$J,358.3,44504,1,0)
 ;;=^358.31IA^4^2
